PL1896022T3 - Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych - Google Patents
Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowychInfo
- Publication number
- PL1896022T3 PL1896022T3 PL05757506T PL05757506T PL1896022T3 PL 1896022 T3 PL1896022 T3 PL 1896022T3 PL 05757506 T PL05757506 T PL 05757506T PL 05757506 T PL05757506 T PL 05757506T PL 1896022 T3 PL1896022 T3 PL 1896022T3
- Authority
- PL
- Poland
- Prior art keywords
- patients
- treatment
- pharmaceutical composition
- upper respiratory
- novel pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NZ2005/000132 WO2006135254A1 (en) | 2005-06-17 | 2005-06-17 | Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion |
| EP05757506A EP1896022B1 (en) | 2005-06-17 | 2005-06-17 | Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1896022T3 true PL1896022T3 (pl) | 2013-03-29 |
Family
ID=37532532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05757506T PL1896022T3 (pl) | 2005-06-17 | 2005-06-17 | Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8603523B2 (pl) |
| EP (1) | EP1896022B1 (pl) |
| AU (2) | AU2005333081B2 (pl) |
| CA (1) | CA2612179C (pl) |
| ES (1) | ES2398960T3 (pl) |
| MX (1) | MX2007016065A (pl) |
| NZ (3) | NZ588134A (pl) |
| PL (1) | PL1896022T3 (pl) |
| WO (1) | WO2006135254A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091084A1 (es) * | 2007-12-07 | 2009-07-23 | Schering Plough Healthcare | Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal |
| MX2011006567A (es) * | 2008-12-19 | 2011-08-03 | Novartis Ag | Formulaciones de fenilefrina con estabilidad mejorada. |
| US10130627B2 (en) | 2008-12-19 | 2018-11-20 | GlaxoSmithKine Consumer Healthcare S.A. | Phenylephrine formulations with improved stability |
| US20110104273A1 (en) * | 2009-11-05 | 2011-05-05 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine |
| US11213480B1 (en) | 2015-08-06 | 2022-01-04 | Hikma Pharmaceuticals International Limited | Phenylephrine hydrochloride ready-to-use solution |
| MX391125B (es) * | 2017-01-26 | 2025-03-21 | Laboratorios Liomont S A De C V | Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282233B1 (en) * | 1980-06-19 | 2000-09-05 | Schering Corp | Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines |
| US5616578A (en) * | 1993-08-26 | 1997-04-01 | The Dupont Merck Pharmaceutical Company | Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor |
| US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
| SK54599A3 (en) | 1996-10-31 | 2000-08-14 | Schering Corp | Composition for the treatment of asthma, containing loratadine and a decongestant |
| US6132758A (en) * | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
| BR0111018A (pt) * | 2000-05-25 | 2004-02-17 | Schering Corp | Formulações estáveis lìquidas e sólidas |
| EA200301223A1 (ru) * | 2001-05-18 | 2004-08-26 | Рэнбакси Лабораториз Лимитед | Лекарственные формы окскарбазепина |
| WO2003089007A1 (en) | 2002-04-22 | 2003-10-30 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| RU2220740C1 (ru) | 2002-08-30 | 2004-01-10 | Гапонюк Петр Яковлевич | Средство для лечения аллергического ринита и аллергического конъюнктивита |
| AU2003272450A1 (en) | 2002-09-13 | 2004-04-30 | C. Steven Smith | Novel composition and method for treatment of upper respiratory conditions |
| AU2004233744A1 (en) * | 2003-05-02 | 2004-11-11 | Warner-Lambert Company Llc | Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance |
| US20050096390A1 (en) * | 2003-10-10 | 2005-05-05 | Per Holm | Compositions comprising fenofibrate and pravastatin |
| NZ555909A (en) * | 2004-12-13 | 2009-11-27 | Mcneil Ppc Inc | Compositions and methods for reducing the degradation of phenylephrine by oxygen |
-
2005
- 2005-06-17 NZ NZ588134A patent/NZ588134A/en not_active IP Right Cessation
- 2005-06-17 PL PL05757506T patent/PL1896022T3/pl unknown
- 2005-06-17 WO PCT/NZ2005/000132 patent/WO2006135254A1/en not_active Ceased
- 2005-06-17 NZ NZ541960A patent/NZ541960A/en not_active IP Right Cessation
- 2005-06-17 ES ES05757506T patent/ES2398960T3/es not_active Expired - Lifetime
- 2005-06-17 EP EP05757506A patent/EP1896022B1/en not_active Expired - Lifetime
- 2005-06-17 MX MX2007016065A patent/MX2007016065A/es active IP Right Grant
- 2005-06-17 NZ NZ575838A patent/NZ575838A/en not_active IP Right Cessation
- 2005-06-17 US US11/922,271 patent/US8603523B2/en not_active Expired - Fee Related
- 2005-06-17 CA CA2612179A patent/CA2612179C/en not_active Expired - Fee Related
- 2005-06-17 AU AU2005333081A patent/AU2005333081B2/en not_active Ceased
-
2009
- 2009-03-27 AU AU2009201201A patent/AU2009201201A1/en not_active Abandoned
- 2009-04-16 US US12/424,765 patent/US20090203727A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005333081A1 (en) | 2006-12-21 |
| CA2612179C (en) | 2016-08-02 |
| MX2007016065A (es) | 2008-03-10 |
| NZ575838A (en) | 2010-10-29 |
| ES2398960T3 (es) | 2013-03-22 |
| AU2005333081B2 (en) | 2010-06-24 |
| US20090215811A1 (en) | 2009-08-27 |
| EP1896022A1 (en) | 2008-03-12 |
| EP1896022B1 (en) | 2012-10-31 |
| WO2006135254A1 (en) | 2006-12-21 |
| US8603523B2 (en) | 2013-12-10 |
| AU2009201201A1 (en) | 2009-04-30 |
| EP1896022A4 (en) | 2008-08-06 |
| CA2612179A1 (en) | 2006-12-21 |
| HK1112407A1 (en) | 2008-09-05 |
| NZ541960A (en) | 2010-01-29 |
| US20090203727A1 (en) | 2009-08-13 |
| NZ588134A (en) | 2010-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195947A (en) | Manicured cyclic compounds and pharmaceutical preparations containing them for use @ for prevention @ and treatment @ for diabetes | |
| ZA200710387B (en) | Method and composition for use in preparation of a patient for surgery | |
| IL200278A (en) | Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness | |
| IL197420A (en) | Polymorphic form of 4 - [3 - (4 - cyclopropanecarbonyl - piperazine - 1 - carbonyl) - 4 - fluoro - benzyl] - h2 - phthalazine - 1 - on, methods of preparation, a pharmaceutical preparation containing it and uses in this form to prepare drugs for the treatment of the human body | |
| IL178038A (en) | Delayed-release oral dosage forms for pain management | |
| GB2444688B (en) | Motorized flosser and method of use | |
| PL1944050T3 (pl) | Ulepszenia odnoszące się do mechanizmów napędowych odpowiednich do stosowania w urządzeniach do podawania leków | |
| PL1601396T3 (pl) | Ulepszenia związane z mechanizmami napędowymi nadającymi się do stosowania w urządzeniach do podawania leków | |
| EP1827391A4 (en) | DOSAGE FORMS AND METHODS OF USE THEREOF | |
| SI2422786T1 (sl) | Nove farmacevtske kombinacije za zdravljenje respiratornih obolenj | |
| GB0523576D0 (en) | Drug composition and its use in therapy | |
| EP1806148A4 (en) | THERAPEUTIC PREPARATION FOR INHALATION | |
| IL182356A0 (en) | Novel cyclic and acyclic propenones and their use in the preparation of medicaments for treating cns disorders | |
| PL1896022T3 (pl) | Nowa kompozycja farmaceutyczna i jej zastosowanie w sposobie leczenia pacjentów z przekrwieniem śluzówki górnych dróg oddechowych | |
| SI2340872T1 (sl) | Nove farmacevtske formulacije, uporabne v zdravljenju nespečnosti | |
| EP1954800A4 (en) | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE | |
| EP1928247A4 (en) | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE | |
| ZA200800469B (en) | Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion | |
| EP1945171A4 (en) | MANUFACTURE OF A MEDICAL DEVICE AND USE IN ALTERNATIVE MEDICINE FOR REHABILITATION TREATMENT OF CHRONIC DISEASES | |
| HU0500516D0 (en) | Medicinal materials of natural origin, their use, process and device for treatment of osteoporosis | |
| EP1968481A4 (en) | DEVICE AND DISTRIBUTION OF MEDICINALLY PURE OXYGEN | |
| GB0406014D0 (en) | Pharmaceutical composition and use | |
| PL1764097T3 (pl) | Sposoby i kompozycje kojące tkanki jamy ustnej i nosa | |
| GB2414682B (en) | Improvements relating to medical respiratory apparatus | |
| PL383272A1 (pl) | Kompozycja farmaceutyczna przydatna w leczeniu chorób wirusowych |